Prolipid

Bioavailability Enhancement

• Proprietary Self Emulsification (SEDDS, SMEDDS) System
  • Proprietary mixtures of excipients
  • Particularly for hydrophobic, lipophilic drugs
• Flexible Dosage Form Options
  • Liquid in a bottle
  • Soft gelatin capsule
  • Hard gelatin capsule
  • Tablets (ProLiquitab)

Potential Benefits:

• Potentially improved therapy
• More rapid onset
• Improved bioavailability
• Lower PK variability
• Higher blood levels
• Lower API requirements

ProLipid Dissolution of CMPD X